Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TNPO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SNX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MKLN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100506748 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NF1P9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101930531 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
USP6NL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC9A7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FCF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPRED1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GFM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAPEPLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPEPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MDN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on